BlackRock’s Eidos Therapeutics, Inc. Common Stock EIDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-1,557,225
| Closed | -$205M | – | 5323 |
|
|
2020
Q4 | $205M | Buy |
1,557,225
+47,477
| +3% | +$6.25M | 0.01% | 1586 |
|
|
2020
Q3 | $76.3M | Buy |
1,509,748
+36,233
| +2% | +$1.83M | ﹤0.01% | 2024 |
|
|
2020
Q2 | $70.2M | Buy |
1,473,515
+56,094
| +4% | +$2.67M | ﹤0.01% | 2044 |
|
|
2020
Q1 | $69.4M | Buy |
1,417,421
+93,732
| +7% | +$4.59M | ﹤0.01% | 1859 |
|
|
2019
Q4 | $76M | Sell |
1,323,689
-11,838
| -0.9% | -$679K | ﹤0.01% | 2101 |
|
|
2019
Q3 | $48M | Sell |
1,335,527
-33,829
| -2% | -$1.22M | ﹤0.01% | 2293 |
|
|
2019
Q2 | $42.6M | Sell |
1,369,356
-244,395
| -15% | -$7.6M | ﹤0.01% | 2392 |
|
|
2019
Q1 | $37.8M | Buy |
1,613,751
+464,387
| +40% | +$10.9M | ﹤0.01% | 2405 |
|
|
2018
Q4 | $15.8M | Buy |
1,149,364
+421,666
| +58% | +$5.8M | ﹤0.01% | 2839 |
|
|
2018
Q3 | $7.26M | Buy |
727,698
+577,698
| +385% | +$5.77M | ﹤0.01% | 3341 |
|
|
2018
Q2 | $3.05M | Buy |
+150,000
| New | +$3.05M | ﹤0.01% | 3569 |
|